Dr. Anthony Fauci to give likely final Covid briefing as top White House health official

Dr. Anthony Fauci to give likely final Covid briefing as top White House health official


NIH National Institute of Allergy and Infectious Diseases Director Anthony Fauci addresses the daily press briefing at the White House in Washington, January 21, 2021.

Jonathan Ernst | Reuters

Dr. Anthony Fauci on Tuesday will give what is expected to be his last public briefing on the Covid-19 pandemic as the White House chief medical advisor.

Fauci announced earlier this year that he will step down in December after serving as the public face of the United States’ coronavirus pandemic response for more than two years.

He will give an update alongside Dr. Ashish Jha, head of the White House Covid task force. They are expected to encourage people to get their Covid boosters and flu shots as soon as possible.

Public health officials have repeatedly warned that the U.S. will likely face another wave of Covid this winter as people travel and gather for the holidays.

CNBC Health & Science

Read CNBC’s latest global health coverage:

The new boosters, which target the variant omicron BA.5, were quickly rolled out in an effort to head off a major surge. But only about 11% of those people eligible have received their shot so far.

The U.S. already facing a severe flu season, with hospitalizations at a decade high.

And respiratory syncytial virus, or RSV, is also hospitalizing children at a much higher rate than in pre-pandemic seasons.

Hospitals and emergency departments are increasingly taxed by people seeking treatment for respiratory illnesses.

Children’s hospitals last week called on the Biden administration to declare a public health emergency to provide more flexibility to address the surge of patients.



Source

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to  billion
Health

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to $12 billion

A startup widely known as “ChatGPT for doctors” raised a new funding round that values the company at $12 billion. OpenEvidence, based in Miami, Florida, closed a $250 million financing, led by Thrive Capital and DST, the company told CNBC. The startup first raised outside capital in February, when it reeled in $75 million from […]

Read More
Another alliance of health care and AI signals why pharma stocks should be back in favor
Health

Another alliance of health care and AI signals why pharma stocks should be back in favor

Bristol Myers Squibb and Microsoft ‘s new partnership aimed at accelerating early detection of lung cancer marks the latest way health care and artificial intelligence are rapidly intersecting. Bristol Myers said on Tuesday it will work with Microsoft’s AI-powered radiology platform to develop and launch imaging algorithms. These new tools, which can be used to […]

Read More
Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry
Health

Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry

US President Donald Trump arrives for an announcement in the Roosevelt Room of the White House in Washington, DC, US, on Friday, Dec. 19, 2025. Will Oliver | Bloomberg | Getty Images Drug pricing. Looming patent cliffs. Dealmaking. The first year of Trump 2.0. Those are among the themes that dominated conversations last week as drugmakers […]

Read More